Cargando…
Differences in survival prognosticators between children and adults with H3K27M‐mutant diffuse midline glioma
AIMS: H3K27M‐mutant diffuse midline glioma (DMG) is a rare and aggressive central nervous system tumor. The biological behavior, clinicopathological characteristics, and prognostic factors of DMG have not yet been completely uncovered, especially in adult patients. This study aims to investigate the...
Autores principales: | Gong, Xuan, Kuang, Shuwen, Deng, Dongfeng, Wu, Jun, Zhang, Longbo, Liu, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651973/ https://www.ncbi.nlm.nih.gov/pubmed/37311690 http://dx.doi.org/10.1111/cns.14307 |
Ejemplares similares
-
Radiotherapy and radio‐sensitization in
H3
(K27M)
‐mutated diffuse midline gliomas
por: Liu, Chao, et al.
Publicado: (2023) -
A validated prognostic nomogram for patients with H3 K27M-mutant diffuse midline glioma
por: Peng, Youheng, et al.
Publicado: (2023) -
Prognostic Implication of Patient Age in H3K27M-Mutant Midline Gliomas
por: Vuong, Huy Gia, et al.
Publicado: (2022) -
Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
por: Banan, Rouzbeh, et al.
Publicado: (2017) -
MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
por: Zhao, Ji-ping, et al.
Publicado: (2022)